Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Annals of Surgery|July 5, 2024
Transplantation Within 6 Months of Registration does not Enhance Survival for Patients with Perihilar CholangiocarcinomaNavine Nasser-Ghodsi, John E Eaton, Byron H Smith, et al.
Research Square|October 27, 2023
IL-17 Signaling in Primary Sclerosing Cholangitis Patient-Derived OrganoidsAna Sofia Garcia Moreno, Maria Eugenia Guicciardi, Alexander Q Wixom, et al.
Hepatology Communications|June 3, 2024
IL-17 signaling in primary sclerosing cholangitis patient-derived organoidsAna S Garcia Moreno, Maria E Guicciardi, Alexander Q Wixom, et al.
Future Oncology (London, England)|July 28, 2025
A Phase 1 study of the novel GCN2 kinase activator NXP800 in patients with advanced cholangiocarcinomaHendrien Kuipers, Joseph J Larson, Caitlin B Conboy, et al.
Hepatology (Baltimore, Md.)|May 25, 2013
Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinomaChristian D Fingas, Joachim C Mertens, Nataliya Razumilava, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Progression in CholangiocarcinomaEmilien Loeuillard, Binbin Li, Hannah E Stumpf, et al.
Cellular and Molecular Gastroenterology and Hepatology|January 14, 2024
Noncanonical TRAIL Signaling Promotes Myeloid-Derived Suppressor Cell Abundance and Tumor Growth in CholangiocarcinomaEmilien J Loeuillard, Binbin Li, Hannah E Stumpf, et al.
Hepatology (Baltimore, Md.)|July 7, 2025
Liver resection with and without vascular resection versus transplantation for de novo perihilar cholangiocarcinomaYawen Dong, Zhihao Li, Vanja Podrascanin, et al.
Pageof 8